Protara Therapeutics is trading at $4.30 (9.7%) up today in pre-market as the move appears driven by light liquidity rather than a clear news catalyst.
- The stock is seeing a notable move from its July 31 closing price of $3.92.
- There are currently no fresh company-specific headlines, earnings, FDA updates, or analyst calls tied to the jump.
- The price action likely reflects a generally firmer risk-on tone across the market.